Integras Partners LLC Invests $2.60 Million in Colgate-Palmolive (NYSE:CL)

Integras Partners LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 28,559 shares of the company’s stock, valued at approximately $2,596,000. Colgate-Palmolive comprises approximately 2.2% of Integras Partners LLC’s investment portfolio, making the stock its 19th largest position.

Several other institutional investors have also modified their holdings of CL. Chicago Partners Investment Group LLC lifted its position in Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at $1,315,000. Fiduciary Alliance LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at $4,066,000. Impact Partnership Wealth LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at $803,000. Finally, Barclays PLC lifted its position in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL opened at $90.41 on Friday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market capitalization of $73.37 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40. The company’s 50 day simple moving average is $89.03 and its 200 day simple moving average is $94.93. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business earned $0.87 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CL. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, Raymond James restated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $101.61.

Check Out Our Latest Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.